ResMed Inc. RMD
$218.27
-$1.31-0.60%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 383.43M | 398.73M | 392.59M | 348.54M | 379.71M |
| Total Depreciation and Amortization | 48.83M | 62.60M | 55.94M | 51.27M | 67.94M |
| Total Amortization of Deferred Charges | 6.29M | 6.43M | 6.39M | 6.40M | 6.34M |
| Total Other Non-Cash Items | 24.45M | 35.20M | 27.12M | 25.86M | 26.02M |
| Change in Net Operating Assets | -8.37M | 51.16M | -142.30M | 25.26M | 58.76M |
| Cash from Operations | 454.63M | 554.13M | 339.75M | 457.32M | 538.77M |
| Capital Expenditure | -51.13M | -33.65M | -28.54M | -42.97M | -30.59M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -325.32M | -24.88M | 0.00 | -522.00K | -138.58M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.21M | 509.00K | -22.40M | -9.09M | 35.45M |
| Cash from Investing | -383.65M | -58.03M | -50.94M | -52.58M | -133.71M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.00M | 0.00 | -5.00M | -- | -5.00M |
| Issuance of Common Stock | 29.31M | 7.43M | 29.56M | 8.21M | 30.16M |
| Repurchase of Common Stock | -200.39M | -175.43M | -195.32M | -150.73M | -100.60M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -87.09M | -87.24M | -87.58M | -87.75M | -77.59M |
| Other Financing Activities | -- | -- | -- | -- | -10.86M |
| Cash from Financing | -263.16M | -255.24M | -258.35M | -230.27M | -163.89M |
| Foreign Exchange rate Adjustments | 905.00K | 2.58M | 2.77M | -71.00K | 35.57M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -191.28M | 243.44M | 33.22M | 174.40M | 276.74M |